1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Clinical characteristics of CXPA
Total Invasive Noninvasive P Value Age (mean) (yr) 64.7 (SD, 13.4) 65.7 (SD, 12.4) 62.7 (SD, 15.3) .30 Sex Male 26 19 7 .44 Female 11 6 5 Location Parotid gland 25 16 9 .68 Submandibular 7 6 1 Minor salivary 5 3 2 Laterality Left 17 9 8 .16 Right 20 16 4 Swelling Yes 32 20 12 .15 No 5 5 0 Pain Yes 13 10 3 .48 No 24 15 9 Infection Yes 2 2 0 1 No 35 23 12 Immobility Yes 12 10 2 .26 No 25 15 10 Nerve palsy Yes 6 6 0 .15 No 31 19 12 Skin infiltration Yes 1 1 0 1 No 36 24 12